Remove Development Remove Pharmaceutical Remove Strategy
article thumbnail

The race to create a vaccine: A conversation with Frank D’Amelio

McKinsey

The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.

article thumbnail

HR Challenges in the Pharmaceutical Industries

Vantage Circle

All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. It pressurizes the healthcare system, both in terms of nature and scale of the demand and healthcare costs and drug development. Be it sales and distribution or product discovery and development. Scarcity of Talent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Make Strategies Stick with Executive Coach, Liz Kislik

Crestcom

How to Make Strategies Stick with Executive Coach, Liz Kislik. On this week’s episode of The Leadership Habit podcast, Jenn Dewall sat down with Liz Kislik to talk about how to make strategies stick. Enjoy our conversation as Liz and Jenn talk about how to make strategies. Why Don’t Our Strategies Stick? I love that.

article thumbnail

Participant Success at Harvard Professional Development Programs

Harvard Professional Development

Taking time away from the day-to-day demands of your job to pursue professional development can be challenging. For many of our participants, the most valuable part of the professional development experience is identifying actionable tips and strategies that they can apply immediately upon the return to the office. Eugene Moore.

article thumbnail

s+b Trend Watch: The Coming Digital Healthcare Landscape

Strategy+Business

Looking toward the future, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones, creating a more connected digital healthcare ecosystem.' Doctors and patients are starting to use digital tools to manage healthcare more efficiently.

article thumbnail

Refueling the innovation engine in vaccines

McKinsey

Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.

article thumbnail

Precision medicine in practice: Strategies for rare cancers

McKinsey

The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.